Corey Davis | LifeSci Advisors |
Glenn Mattes | President, CEO & Director |
Kirk Coleman | CFO, Treasurer & Secretary |
Christopher Cano | COO & VP, Business Development |
Bill Williams | University of Texas, Austin |
Dale Christensen | Head, Clinical Development |
Jonathan Aschoff | ROTH Capital Partners |
Daniel Carlson | TW Research |
Yuan Zhi | B. Riley Securities |
Richard Deutsch | National Securities. |
Ted Ketterer | TK Associates |
Good day, and welcome to the TFF Pharmaceuticals, Inc.
First Quarter 2020 Earnings Conference Call. [Operator Instructions]. I would now like to turn the conference over to Corey Davis. Please go ahead.